用語

 Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents  Frenck RW Jr, Klein NP, Kitchin N, et al.　〔N Engl J Med. 2021 Jul 15;385(3):239-250〕青少年（12～15歳）におけるCOVID-19ワクチンBNT162b2の安全性，免疫原性および有効性　（日本語概要）Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children Dionne A, Sperotto F, Chamberlain S, et al.　〔JAMA Cardiol. 2021 Aug 10;e213471〕小児の症例集積研究における心筋炎とCOVID-19 mRNAワクチンBNT162b2との関連　（日本語概要）Evaluation of...

 Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study Gray KJ, Bordt EA, Atyeo C, et al.　〔Am J Obstet Gynecol. 2021 Mar 26:S0002-9378(21)00187-3〕妊婦および授乳婦におけるCOVID-19ワクチンの反応（日本語概要）SARS-CoV-2 Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women (Research Letter) Perl SH, Uzan-Yulzari A, Klainer H, et al.　〔JAMA. 2021 May 18;325(19):2013-2014〕COVID-19ワクチン接種後の授乳婦の母乳に検出されるSARS-CoV-2特異的抗体（リサーチレター）（日本語概要） Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant...

 Antibody Responses to SARS-CoV-2 after Infection or Vaccination in Children and Young Adults with Inflammatory Bowel Disease  Dailey J, Kozhaya L, Dogan M, et al.　〔medRxiv. 2021 Jun 15〕 炎症性腸疾患を有する小児および若年成人におけるSARS-CoV-2の感染後またはワクチン接種後の抗体反応　（日本語概要）  Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab...

変異株に対する免疫応答  Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization  Planas D, Veyer D, Baidaliuk A, et al.　〔Nature. 2021 Aug;596(7871):276-280〕 SARS-CoV-2デルタ変異株は抗体による中和への感受性が低下　（日本語概要）  mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar  Chemaitelly...

 Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351(CORRESPONDENCE) Shen X, Tang H, Pajon R, et al.　〔N Engl J Med. 2021 Jun 17;384(24):2352-2354〕SARS-CoV-2変異株B.1.429およびB.1.351に対する中和活性（Editorへのレター）　（日本語概要） Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant Shinde V, Bhikha S, Hoosain Z, et al.　〔N Engl J Med. 2021 May 20;384(20):1899-1909〕B.1.351変異株に対するNVX-CoV2373 COVID-19ワクチンの有効性　（日本語概要） Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine Heath P, Galiza EP, Baxter DN, et al.　〔N Engl J...